Study of Homologous Autoimplantation Therapy for Treatment of Multiple Warts in Patients Attending the Dermatology out Patient Department

Jump To References Section

Authors

  • Anil S. Gugle
     ,IN
  • Vikrant M. Jadhav
     ,IN
  • Rahul Kote
     ,IN
  • Milind Devidas Deshmukh
     ,IN
  • Divyank Vankawala
     ,IN

Keywords:

Homologous Autoimplantation, Warts.
Education and Research

Abstract

Introduction: Warts are benign tumours that commonly involve skin and other epithelial tissues. There is no single treatment modality that is 100% effective. In multiple warts, especially on face, palms, and soles destructive procedure are inappropriate and impractical. Homologous autoimplantation is a simple technique, which helps in inducing cell mediated response, causing clearance of warts. Aims and objectives: To evaluate the effect of homologous autoimplantation therapy in treatment of multiple warts. To study the untoward effects of this treatment. Material and methods: A total of 49 patients of viral warts were included in study. Homologous autoimplantation of wart was done and regular follow up was done to see the result. Results: Out of 49 patients, in 24 patients there was good response, 14 showed moderate response, 5 showed poor response and in 6 patients there was no response. Conclusion: Homologous autoimplantation is an easy, minimally invasive technique which clears multiple, recurrent and recalcitrant warts.

Downloads

Published

2015-12-01

Issue

Volume 2, Issue 2, July-December 2015

Section

Original Research Article

 

References

Drake LA, Ceilley RI, Cornelison RL, Dobes WL, Dorner W, Goltz RW, et al. Guidelines of care for warts: Human papilloma viruses. J AM AcadDermatol. 1995 Jan; 32(1):98-103.

Srivastava PK, Bajaj AK. Autowart injection therapy for recalcitrant warts. Indian J Dermatol. 2010 Oct-Dec; 55(4): 367-9.

Lipke MM. An Armamentarium of Wart Treatments. Clin Med Res. 2006 Dec; 4(4):273-93.

Sterling JC, Handfield-Jones S, Hudson PM. British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001 Jan; 144(1):4-11.

Androphy EJ, Lowy DR. ‘Warts', in Klaus Wolff, Lowell A. Goldsmith, Amy S. Paller, David J. Leffell. Fitzpatrick's Dermatology in General Medicine. 7th ed. Vol. 2. United States of America: The McGraw-Hill Companies; 2008. p. 1914-23.

Shivkumar V, Okade R, Rajkumar V. Autoimplantation therapy for multiple warts. Indian J Dermatolvenerolleprol. 2009 Nov-Dec; 75(6):593-5.

Viac J, Thivolet J, Hegary MR, Chardonnet Y, Dambuyant C. Comparative study of delyed hypersensitivity skin reaction and antibodies to human papilloma virus. ClinExpimmunol. 1997; 29(2):240-6.

Nischal KC, et al. A novel modification of autoimplantation therapy for the treatment of multiple recurrent and palmoplantar warts. J Cutanaestsurg. 2012 Jan-Mar; 5(1):26-9.

Kuykendall-Ivy TD, Johnson SM. Evidence-based review of managementof nongenital cutaneous warts. Cutis. 2003 Mar; 71(3):213-22.

Viac J, Thivolet J, Chardonnet Y. Specific immunity in patients sufferingfrom recurring warts before and after repetitive intradermal tests withhuman papilloma virus. Br J Dermatol. 1977 Oct; 97(4):365-70.

Venugopal SS, Murrell DF. Recalcitrant Cutaneous warts treated with recombinant quadrivalent human papilloma virus vaccine (types 6, 11, 16and 18) in a developmentally delayed, 31-year-old white man. ArchDermatol. 2010 May; 146(5):475-7.

Kreuter A, Waterboer T, Wieland U. Regression of Cutaneous warts ina patient with WILD syndrome following recombinant quadrivalent humanpapilloma virus vaccination. Arch Dermatol. 2010 Oct; 146(10):1196-7.

Briggaman RA, Wheeler CE Jr. Immunology of human warts. J Am Acad Dermatol. 1979 Oct; 1(4):297-304.